siRNA treatment reduces triglycerides in people along with unusual disorder
.INVESTIGATION EMPHASIZE.19 September 2024.
Plozasiran reduced triglyceride degrees by 80% and reduced the danger of pancreatitis in individuals with persistent chylomicronemia, with or without a genetic diagnosis.